FindAPhD Weekly PhD Newsletter | JOIN NOW FindAPhD Weekly PhD Newsletter | JOIN NOW

5G-IoT in the fight against Auto-immune diseases

   Faculty of Engineering, Computing and the Environment

  ,  Applications accepted all year round  Self-Funded PhD Students Only

About the Project

The empowerment of patients and their formal and informal carers has become a prime target of healthcare strategy development in Europe and elsewhere.

Emerging new network technologies (LTE, 5G, IoT) allowing for SDN and NFV will form the backbone of future healthcare, enabling the Internet of Things, Smart Pharmaceuticals and Individualized Medicine. Cloud computing, Big Data and enhanced security will enable virtualization and individualization of care and allow the application of Industry 4.0 design principles in health care.
Technologies such as 5G IoT or LoRa are new Radio Access Technologies utilizing alternative frequencies to enable “Things” in a medical universe. These technologies, which empower sensors to allow the connection of the physical world (biological system) and the virtual world (platform) are likely to become components of what is about to become 5G.

A prerequisite for treatment success with auto-immune (AI) diseases, similarly to most chronic diseases, is the regular intake or administration of drugs, that is, a high adherence to therapy. In order to improve the patient’s QoL and reduce the burden on society, AI patients should be comprehensively assessed while being empowered to remain active both in their family and social lives as well as in their work environment. This can be achieved by providing optimal care (rehabilitation, multi-disciplinary assessment and services and so on) and medication adapted to the needs of every single patient. In order to better meet the patients’ needs, good communication and collaboration between the different stakeholders is essential. This includes AI patients, their caregivers, policy makers, healthcare professionals, researchers, regulators and payers. Unfortunately, a wide variation in access to care and treatment exists nowadays across European countries and globally. New technologies allowing e-communication may be of help to facilitate optimal care and (self-) management. In the new era of AI diseases treatment and on the basis of our current knowledge about their management, it became pretty clear that the overall therapeutic strategy should always be scheduled on strictly individualized basis. To this end, AI patients should be encouraged to take control over their own disease. They should be educated to record any change in their condition together with any potentially relevant factor they may notice or on the basis of their doctor’s advice. The advent of 5G-IoT can support patients in doing so and provide tools in supporting various parameters recording in real time. Relevant clinical studies may further highlight the importance of advanced technology in AI diseases management.

Funding Notes

There is no funding for this project: applications can only be accepted from self-funded candidates

Email Now

PhD saved successfully
View saved PhDs